Parasites, Hosts and Diseases

  • 제46권3호
  • /
  • Pages.119-125
  • /
  • 2008
  • /
  • 2982-5164(pISSN)
  • /
  • 1738-0006(eISSN)
대한기생충학·열대의학회 (The Korea Society for Parasitology and Tropical Medicine)
권호 표지
DOI QR코드

DOI QR Code

Clinical and Pathological Aspects of Filarial Lymphedema and Its Management

  • Shenoy, R.K. (Filariasis Chemotherapy Unit, T. D. Medical College Hospital)
  • 발행 : 2008.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Lymphatic filariasis, transmitted by mosquitoes is the commonest cause of lymphedema in endemic countries. Among 120 million infected people in 83 countries, up to 16 million have lymphedema. Microfilariae ingested by mosquitoes grow into infective larvae. These larvae entering humans after infected mosquito bites grow in the lymphatics to adult worms that cause damage to lymphatics resulting in dilatation of lymph vessels. This earliest pathology is demonstrated in adults as well as in children, by ultrasonography, lymphoscintigraphy and histopathology studies. Once established, this damage was thought to be irreversible. This lymphatic damage predisposes to bacterial infection that causes recurrent acute attacks of dermato-lymphangio-adenitis in the affected limbs. Bacteria, mainly streptococci gain entry into the lymphatics through 'entry lesions' in skin, like interdigital fungal infections, injuries, eczema or similar causes that disrupt integrity of skin. Attacks of dermato-lymphangio-adenitis aggravates lymphatic damage causing lymphedema, which gets worse with repeated acute attacks. Elephantiasis is a late manifestation of lymphatic filariasis, which apart from limbs may involve genitalia or breasts. Lymphedema management includes use of antifilarial drugs in early stages, treatment and prevention of acute attacks through 'limb-hygiene', antibiotics and antifungals where indicated, and physical measures to reduce the swelling. In selected cases surgery is helpful.

키워드

참고문헌

  1. World Health Organization. Bridging the Gaps World Health Report. Geneva, Switzerland. WHO. 1995
  2. Michael E, Bundy DAP, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996; 112: 409-428 https://doi.org/10.1017/S0031182000066646
  3. Ramaiah KD, Ramu K, Guyatt H, Vijayakumar KN, Pani SP. Direct and indirect costs of acute form of lymphatic filariasis in rural areas in Tamil Nadu, South India. Trop Med Int Hlth 1998; 3: 108-115 https://doi.org/10.1046/j.1365-3156.1998.00208.x
  4. Pani SP, Yuvaraj J, Vanamail P, Dhanda V, Michael E, Grenfell BT, Bundy DAP. Episodic adenolymphangitis and lymphedema in patients with bancroftian filariasis. Trans Roy Soc Trop Med Hyg 1995; 89: 72-74 https://doi.org/10.1016/0035-9203(95)90666-5
  5. Ramaiah KD, Das PK, Michael E, Guyatt H. Economic burden of lymphatic filariasis in India. Parasitol Today 2000; 16: 251-253 https://doi.org/10.1016/S0169-4758(00)01643-4
  6. Centers for Disease Control and Prevention, Atlanta, USA. Recommendations of the International Task Force for Disease Eradication. MMWR 1993; 42: 1-38
  7. Ottesen EA. Towards elimination of lymphatic filariasis. In Angelico M, Rocchi G eds, Infectious Diseases and Public Health. Tel Aviv, Israel. Balaban Publishers. 1998, p 58-64
  8. Seim AR, Dreyer G, Addiss DG. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Rev Soc Brasil Med Trop 1999; 32: 325-328 https://doi.org/10.1590/S0037-86821999000300022
  9. Noroes J, Addiss D, Amaral F, Coutinho A, Medeiros Z, Dreyer G. Occurrence of adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia. Trans Roy Soc Trop Med Hyg 1996; 90: 55-56 https://doi.org/10.1016/S0035-9203(96)90478-2
  10. Dreyer G, Noroes J, Addiss D, Santos A, Medeiros Z, Figueredo- Silva J. Bancroftian filariasis in a paediatric population: a ultrasonographic study. Trans Roy Soc Trop Med Hyg 1999; 93: 633- 636 https://doi.org/10.1016/S0035-9203(99)90078-0
  11. Mand S, Debrah A, Basta L, Adjei O, Hoerauf A. Reliable and frequent detection of adult Wuchereria bancrofti in Ghanian women by ultrasonography. Trop Med Int Hlth 2004; 9: 1111-1114 https://doi.org/10.1111/j.1365-3156.2004.01304.x
  12. Fox LM, Furness BW, Haser JK, Brissau JM, Louis-Charles J, Wilson SF, Addiss DG, Lammie PJ, Beach M. Ultrasonographic examination of Haitian children with lymphatic filariasis: a longitudinal assessment in the context of antifilarial drug treatment. Am J Trop Med Hyg 2005; 72: 642-648
  13. Shenoy RK, Suma TK, Kumaraswami V, Padma S, Rahmah N, Abhilash G, Ramesh C. Doppler ultrasonography detects adult worm nests in lymph vessels of children with brugian filariasis. Ann Trop Med Parasitol 2007; 101: 173-180 https://doi.org/10.1179/136485907X154566
  14. Freedman DO, de Alemeida Filho PJ, Besh S, Maia e Silva MC, Braga C, Maciel A. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis 1994; 170: 927-933 https://doi.org/10.1093/infdis/170.4.927
  15. Shenoy RK, Suma TK, Kumaraswami V, Rahmah N, Dhananjayan G, Padma S, Abhilash G, Ramesh C. Preliminary findings from a cross-sectional study on lymphatic filariasis in children in an area endemic for Brugia malayi infection. Ann Trop Med Parasitol 2007; 101: 205-213 https://doi.org/10.1179/136485907X154548
  16. Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 2005; 6: 179-200 https://doi.org/10.1517/14656566.6.2.179
  17. Freedman DO, Bui T, de Almeida Filho PJ, Braga C, Maia E, Silva MC, Maciel A, Furtado AE. Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. Am J Trop Med Hyg 1995; 52: 258-261 https://doi.org/10.4269/ajtmh.1995.52.258
  18. Shenoy RK, Sandhya K, Suma TK, Kumaraswami V. A Preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. Southeast Asian J Trop Med Pub Hlth 1995; 26: 301-305
  19. Shenoy RK, Kumaraswami V, Suma TK, Rajan K, Radhakuttyamma G. A double blind placebo controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphedema caused by brugian filariasis. Ann Trop Med Parasitol 1999; 93: 367-377 https://doi.org/10.1080/00034989958366
  20. Suma TK, Shenoy RK, Varghese J, Kuttikkal VV, Kumaraswami V. Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filariasis. Southeast Asian J Trop Med Pub Hlth 1997; 28: 826- 830
  21. Vincent AL, Urena-Rojas CA, Ayoub EM, Ottesen EA, Harden EG. Filariasis and erisipela in Santo Dominigo. J Parasitol 1998; 84: 557-561 https://doi.org/10.2307/3284723
  22. Olszewski WL, Jamal S. Skin bacterial factor in progression of filarial lymphedema. Lymphology 1994; 27: 148-149
  23. Olszewski WL, Jamal S, Manokaran G, Pani S, Kumaraswami V, Kubica U, Lukomska B, Dworczynski A, Swoboda E, Meisel- Mikolajczyk E. Bacteriologic studies of skin, tissue fluid, lymph and lymph nodes in patients with filarial lymphedema. Am J Trop Med Hyg 1997; 57: 7-15 https://doi.org/10.4269/ajtmh.1997.57.7
  24. Shenoy RK, Suma T K, Rajan K, Kumaraswami V. Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Ann Trop Med Parasitol 1998; 92: 587-594 https://doi.org/10.1080/00034989859285
  25. Weil GJ, Ramzy RM, Chandrashekhar R, Gad AM, Lowrie RC Jr, Faris R. Parasite antigenemia without microfilaremia in bancroftian filariasis. Am J Trop Med Hyg 1996; 55: 333-337 https://doi.org/10.4269/ajtmh.1996.55.333
  26. World Health Organization. Lymphatic filariasis: the disease and its control. WHO Tech Rep Ser 1992; no. 821
  27. Kumaraswami V. The clinical manifestations of Lymphatic Filariasis. In: TB Nutman ed, Lymphatic Filariasis. London, U.K. Imperial College Press. 2000, p 103-125
  28. Burri H, Loutan L, Kumaraswami V, Vijayasekaran V. Skin changes in chronic lymphatic filariasis. Trans Roy Soc Trop Med Hyg 1996; 90: 671-674 https://doi.org/10.1016/S0035-9203(96)90428-9
  29. Ottesen EA. c. Springer Semin Immunopathol 1980; 2: 373-385
  30. Partono F. The spectrum of diseases in lymphatic filariasis. Ciba Foundation Sym 1987; 127: 15-31
  31. Dreyer G, Medeiros Z, Netto MJ, Leal NC, Gonzaga de Castro L, Peissens WF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans Roy Soc Trop Med Hyg 1999; 93: 413-417 https://doi.org/10.1016/S0035-9203(99)90140-2
  32. Panicker KN, Sebasan S. Socioeconomic perspectives. Miscellaneous publications of VCRC. 1990; 16: 42-47
  33. Ramaiah KD, Kumar KN. Effect of lymphatic filariasis on school children. Acta Tropica 2000; 76: 197-199 https://doi.org/10.1016/S0001-706X(00)00102-9
  34. Witt C, Ottesen EA. Lymphatic filariasis: an infection of childhood. Trop Med Int Hlth 2001; 6: 582-606 https://doi.org/10.1046/j.1365-3156.2001.00765.x
  35. Lammie PJ, Reiss MD, Dimock KA, Streit TG, Roberts JM, Eberhard ML. Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. Am J Trop Med Hyg 1998; 59: 217-221 https://doi.org/10.4269/ajtmh.1998.59.217
  36. Suma TK. Shenoy RK, Kumaraswami V. Efficacy and sustainability of foot-care programme in preventing acute attacks of adenolymphangitis (ADL) in brugian filariasis. Trop Med Int Hlt 2002; 7: 763-766 https://doi.org/10.1046/j.1365-3156.2002.00914.x
  37. Dreyer G, Noroes J, Figueredo-Silva, Piessens WF. Pathogenesis of lymphatic disease in bancroftian filariasis. Parasitol Today 2000; 16: 544-548 https://doi.org/10.1016/S0169-4758(00)01778-6
  38. Addiss DG, Dreyer G. Treatment of lymphatic filariasis. In Nutman TB ed, Lymphatic Filariasis. London, U.K. Imperial College Press. 2000, p 151-199
  39. Dreyer G, Medeiros Z, Netto MJ, Leal NC, Gonzaga de Castro L, Peissens WF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans Roy Soc Trop Med Hyg 1999; 93: 413-417 https://doi.org/10.1016/S0035-9203(99)90140-2
  40. Ottesen EA, Duke BOL, Karam M, Bebehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997; 75: 491-503
  41. Pani SP, Lall R. Clinical features, pathogenesis and management of lymphatic filariasis. ICMR Bull 1998; 28: 41-51
  42. Jamal S, Pani SP. Filarial lymphedema - Reduction by surgery immediate and late results. Progress in lymphology. XVII - Proceedings of the 17th Int Congr Lymphol, Chennai, India, 19-25 September, 1999, 147-150
  43. Casley-Smith JR. Management of lymphedema in India - A suggested protocol for prevention and treatment. Progress in lymphology. XVII - Proceedings of the 17th Int Congr Lymphol, Chennai, India, 19-25 September, 1999, 151-154

피인용 문헌

  1. Filariasis: diagnosis and treatment vol.22, pp.6, 2008, https://doi.org/10.1111/j.1529-8019.2009.01271.x
  2. Lymphatic filariasis and onchocerciasis vol.376, pp.9747, 2008, https://doi.org/10.1016/s0140-6736(10)60586-7
  3. An Unusual Case of Adult Filarial Oophoritis : vol.30, pp.6, 2008, https://doi.org/10.1097/pgp.0b013e31821cabe2
  4. Lymphedema in a guyanan migrant. vol.18, pp.1, 2008, https://doi.org/10.1111/j.1708-8305.2010.00472.x
  5. Modeling, docking, simulation, and inhibitory activity of the benzimidazole analogue against β-tubulin protein from Brugia malayi for treating lymphatic filariasis vol.21, pp.9, 2008, https://doi.org/10.1007/s00044-011-9763-5
  6. Global Elimination of Lymphatic Filariasis: A “Mass Uprising of Compassion” vol.7, pp.8, 2008, https://doi.org/10.1371/journal.pntd.0002264
  7. Lymphatic filariasis morbidity mapping: a comprehensive examination of lymphoedema burden in Chikwawa district, Malawi vol.108, pp.12, 2008, https://doi.org/10.1093/trstmh/tru150
  8. Bone Morphogenetic Protein 2 Signaling Negatively Modulates Lymphatic Development in Vertebrate Embryos vol.114, pp.1, 2008, https://doi.org/10.1161/circresaha.114.302452
  9. Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase vol.20, pp.6, 2008, https://doi.org/10.1007/s00894-014-2266-9
  10. Detecting and staging podoconiosis cases in North West Cameroon: positive predictive value of clinical screening of patients by community health workers and researchers vol.16, pp.1, 2008, https://doi.org/10.1186/s12889-016-3669-6
  11. Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India vol.95, pp.4, 2016, https://doi.org/10.4269/ajtmh.16-0286
  12. The diagnostic challenge of mapping elephantiasis in the Tigray region of northern Ethiopia vol.55, pp.5, 2008, https://doi.org/10.1111/ijd.13120
  13. The Potentials and Pitfalls of Microarrays in Neglected Tropical Diseases: A Focus on Human Filarial Infections vol.5, pp.3, 2008, https://doi.org/10.3390/microarrays5030020
  14. Lymphatic Endothelial Cells under Mechanical Stress: Altered Expression of Inflammatory Cytokines and Fibrosis vol.15, pp.2, 2008, https://doi.org/10.1089/lrb.2016.0042
  15. Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis vol.11, pp.5, 2008, https://doi.org/10.1371/journal.pntd.0005610
  16. Lymphatic Filariasis Increases Tissue Compressibility and Extracellular Fluid in Lower Limbs of Asymptomatic Young People in Central Myanmar vol.2, pp.4, 2017, https://doi.org/10.3390/tropicalmed2040050
  17. Lymphatic Filariasis Presenting as a Swelling over the Upper Arm: A Case Report vol.12, pp.1, 2008, https://doi.org/10.5704/moj.1803.016
  18. The History of Bancroftian Lymphatic Filariasis in Australasia and Oceania: Is There a Threat of Re-Occurrence in Mainland Australia? vol.3, pp.2, 2008, https://doi.org/10.3390/tropicalmed3020058
  19. Scrotal reconstruction on scrotal lymphedema vol.20, pp.None, 2008, https://doi.org/10.1016/j.eucr.2018.04.009
  20. Integrated morbidity mapping of lymphatic filariasis and podoconiosis cases in 20 co-endemic districts of Ethiopia vol.12, pp.7, 2008, https://doi.org/10.1371/journal.pntd.0006491
  21. Polyphenol enriched ethanolic extract of Cajanus scarabaeoides (L.) Thouars exerts potential antifilarial activity by inducing oxidative stress and programmed cell death vol.13, pp.12, 2008, https://doi.org/10.1371/journal.pone.0208201
  22. Laboratory Evaluation of a Rapid IgG4 Antibody Test (BLF Rapid™) for Bancroftian Filariasis vol.99, pp.6, 2008, https://doi.org/10.4269/ajtmh.18-0566
  23. Elimination of lymphatic filariasis in South East Asia vol.364, pp.None, 2019, https://doi.org/10.1136/bmj.k5198
  24. Comparison of quantitative analysis to qualitative analysis for interpretation of lower-limb lymphoscintigraphy vol.18, pp.1, 2019, https://doi.org/10.4103/wjnm.wjnm_17_18
  25. Evaluation of lymphatic filariasis in endemic area of Brazil where mass drug administration is not required vol.113, pp.3, 2019, https://doi.org/10.1080/20477724.2019.1623546
  26. Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease vol.6, pp.6, 2008, https://doi.org/10.14309/crj.0000000000000075
  27. Antifilarial activity of azadirachtin fuelled through reactive oxygen species induced apoptosis: a thorough molecular study on Setaria cervi vol.93, pp.5, 2008, https://doi.org/10.1017/s0022149x18000615
  28. Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections vol.4, pp.3, 2008, https://doi.org/10.3390/tropicalmed4030108
  29. Surgical Treatment of Advanced Lymphatic Filariasis of Lower Extremity Combining Vascularized Lymph Node Transfer and Excisional Procedures vol.17, pp.6, 2019, https://doi.org/10.1089/lrb.2018.0058
  30. Prevalence and Correlates of Lymphatic Filariasis Infection and Its Morbidity Following Mass Ivermectin and Albendazole Administration in Mkinga District, North-Eastern Tanzania vol.9, pp.5, 2008, https://doi.org/10.3390/jcm9051550
  31. An Insight into the Discovery of Potent Antifilarial Leads Against Lymphatic Filariasis vol.21, pp.7, 2020, https://doi.org/10.2174/1389450120666191204152415
  32. Economic Costs and Benefits of Community-Based Lymphedema-Management Programs for Lymphatic Filariasis in India vol.103, pp.1, 2008, https://doi.org/10.4269/ajtmh.19-0898
  33. Possible Role of the RORC Gene in Primary and Secondary Lymphedema: Review of the Literature and Genetic Study of Two Rare Causative Variants vol.19, pp.2, 2008, https://doi.org/10.1089/lrb.2020.0030
  34. Therapeutic Efficacy of Anti-Bestrophin Antibodies against Experimental Filariasis: Immunological, Immune-Informatics and Immune Simulation Investigations vol.10, pp.2, 2008, https://doi.org/10.3390/antib10020014
  35. Filariasis and transfusion‐associated risk: a literature review vol.116, pp.7, 2021, https://doi.org/10.1111/vox.13073
  36. A model for self-management of chronic filarial lymphoedema with acute dermato-lymphangio-adenitis vol.14, pp.11, 2008, https://doi.org/10.1136/bcr-2021-244721
  37. Substernal goitre presenting with upper and lower extremity oedema vol.14, pp.11, 2008, https://doi.org/10.1136/bcr-2021-245036
  38. Stewart‐Treves syndrome and other cutaneous malignancies in the context of chronic lymphedema: a systematic review vol.61, pp.1, 2022, https://doi.org/10.1111/ijd.15736